BMY |
Bristol-Myers Squibb Company |
0 |
8.87% |
|
|
|
|
|
N/A |
0.00% |
31.00% |
27.64% |
---|
PFE |
Pfizer Inc. |
0 |
7.20% |
|
|
|
|
|
N/A |
0.00% |
26.97% |
13.94% |
---|
ABBV |
AbbVie Inc. |
0 |
7.09% |
|
|
|
|
|
N/A |
0.00% |
27.65% |
25.61% |
---|
JNJ |
Johnson & Johnson |
0 |
6.83% |
|
|
|
|
|
N/A |
0.00% |
19.10% |
20.87% |
---|
MRK |
Merck & Co., Inc. |
0 |
6.56% |
|
|
|
|
|
N/A |
0.00% |
36.29% |
48.54% |
---|
GILD |
Gilead Sciences, Inc. |
0 |
4.60% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
---|
CAH |
Cardinal Health, Inc. |
0 |
4.13% |
|
|
|
|
|
N/A |
0.00% |
23.73% |
24.05% |
---|
VTRS |
Viatris Inc. |
0 |
4.05% |
|
|
|
|
|
N/A |
0.00% |
30.87% |
29.47% |
---|
UTHR |
United Therapeutics Corporation |
0 |
3.75% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
32.21% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
0 |
3.56% |
|
|
|
|
|
N/A |
0.00% |
31.17% |
52.18% |
---|
ZTS |
Zoetis Inc. |
0 |
3.49% |
|
|
|
|
|
N/A |
0.00% |
29.70% |
24.44% |
---|
LLY |
Eli Lilly and Company |
0 |
3.19% |
|
|
|
|
|
N/A |
0.00% |
40.95% |
42.16% |
---|
AMGN |
Amgen Inc. |
0 |
3.07% |
|
|
|
|
|
N/A |
0.00% |
34.50% |
47.20% |
---|
BIIB |
Biogen Inc. |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
37.26% |
39.84% |
---|
OGN |
Organon & Co. |
0 |
2.42% |
|
|
|
|
|
N/A |
0.00% |
45.12% |
74.83% |
---|
CRL |
Charles River Laboratories International... |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
44.67% |
27.17% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.34% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
---|
MEDP |
Medpace Holdings, Inc. |
0 |
1.86% |
|
|
|
|
|
N/A |
0.00% |
56.20% |
24.23% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
0 |
1.61% |
|
|
|
|
|
N/A |
0.00% |
34.71% |
19.89% |
---|
ELAN |
Elanco Animal Health Incorporated |
0 |
1.60% |
|
|
|
|
|
N/A |
0.00% |
53.28% |
18.79% |
---|
ALKS |
Alkermes plc |
0 |
1.13% |
|
|
|
|
|
N/A |
0.00% |
55.46% |
60.80% |
---|
EXEL |
Exelixis, Inc. |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
35.76% |
25.36% |
---|
HALO |
Halozyme Therapeutics, Inc. |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
37.56% |
28.21% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
28.23% |
22.40% |
---|
PRGO |
Perrigo Company plc |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
43.05% |
20.57% |
---|
CORT |
Corcept Therapeutics Incorporated |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
65.42% |
36.69% |
---|
TGTX |
TG Therapeutics, Inc. |
0 |
0.74% |
|
|
|
|
|
N/A |
0.00% |
55.57% |
32.86% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
68.70% |
21.79% |
---|
ACLX |
Arcellx, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
38.93% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
|
0.63% |
|
|
|
|
|
|
|
|
|
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
0.62% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
10.53% |
---|
TWST |
Twist Bioscience Corporation |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
66.71% |
37.00% |
---|
VCEL |
Vericel Corporation |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
58.27% |
74.40% |
---|
INCY |
Incyte Corporation |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
42.37% |
45.07% |
---|
ADMA |
ADMA Biologics, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
61.47% |
8.15% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
52.38% |
63.01% |
---|
ROIV |
Roivant Sciences Ltd. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
32.36% |
51.52% |
---|
EXAS |
Exact Sciences Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
46.55% |
11.01% |
---|
BPMC |
Blueprint Medicines Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
66.68% |
-1.50% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
67.35% |
47.41% |
---|
INSM |
Insmed Incorporated |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
46.27% |
69.48% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
82.04% |
56.49% |
---|
KRYS |
Krystal Biotech, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
46.99% |
18.43% |
---|
KYMR |
Kymera Therapeutics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
67.60% |
14.75% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
35.06% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
29.42% |
23.44% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
57.02% |
22.76% |
---|
RNA |
Avidity Biosciences, Inc. |
0 |
0.36% |
|
|
|
|
|
N/A |
0.00% |
67.15% |
53.95% |
---|
VKTX |
Viking Therapeutics, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
56.48% |
7.87% |
---|
MYGN |
Myriad Genetics, Inc. |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
60.35% |
59.06% |
---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
---|